{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Purple Biotech Ltd."},"Symbol":{"label":"Symbol","value":"PPBT"},"Address":{"label":"Address","value":"4 OPPENHEIMER STREET,SCIENCE PARK, REHOVOT, 7670104, Israel"},"Phone":{"label":"Phone","value":"+972 39333121"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24."},"CompanyUrl":{"label":"Company Url","value":"https://www.purple-biotech.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bertrand C. Liang","title":"Chief Medical Officer"},{"name":"Gil Efron","title":"Chief Executive Officer"},{"name":"Hadas Reuveni","title":"Vice President-Research & Development"},{"name":"Ido Morpurgo","title":"Vice President-Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}